This report provides comprehensive information on the current therapeutic developmental pipeline of Quest Pharma Tech Inc. s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Enquiry @ http://www.researchbeam.com/quest-pharmatech-inc-product-pipeline-review-2015-market/enquire-about-report
Companyprofilesandconferences.com glad to promote a new report on "Antares Pharma, Inc. (ATRS) - Product Pipeline Analysis" which is a specialty pharmaceutical company, focusing on the self-injection pharmaceutical drugs and technologies and topical gel-based products.
The major players in the erythropoietin (EPO) market are Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc, and LG Life Sciences Ltd... @ @ https://bit.ly/3h7BVom
Title: Identifying Technological spillovers and product market rivalry: theory and evidence from a panel of U.S. firms Author: Schankerman Created Date
Big Market Research, Tetraphase Pharmaceuticals Inc. Product Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014.Global Markets Direct’s, ‘Tetraphase Pharmaceuticals Inc. - Product Pipeline Review - 2014’, provides an overview of the Tetraphase Pharmaceuticals Inc.’s pharmaceutical research and development focus.
The Global Needle-free Injection Systems Market size is expected to reach $24.9 billion by 2023, rising at a market growth of 17.4% CAGR during the forecast period. Full Report: http://kbvresearch.com/needle-free-injection-systems-market/
It sounds a bit harsh, yet when it comes to new product launches, that has increasingly been the pharmaceutical industry's experience since the recession.
Global Functional Food Products Market size is expected to rise at a significant CAGR during the forecast period. Get more details @ https://goo.gl/REoj8c
Get more details @ http://bit.ly/2ekRPfD Some of the major players of global precision medicine market are Intomics, F. Hoffmann-La Roche, NanoString Technologies, Laboratory Corporation of America Holdings, Biocrates Life Sciences, Teva Pharmaceutical, Tepnel Pharma Services, Novartis, Silicon Biosystems, Quest Diagnostics and Ferrer InCode.
Get more details @ http://bit.ly/2ekRPfD Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics.
Some key players in the Saudi Arabia pharmaceutical market covered in this report are SPIMACO, Tabuk Pharmaceuticals Manufacturing Co., Juphar, Jamjoom Pharma, GlaxoSmithKline plc. Pfizer Inc., Novartis AG and Sanofi.
Global oncology drugs market is projected to grow at a brisk rate over the forecast period owing to widespread prevalence of cancer, globally. Various other related factors which are contributing to the growth of oncology drugs market include rise in geriatric population worldwide, increase in global healthcare expenditure, rising number of product approvals by regulatory bodies and growing R&D activities for the development of new cancer drugs.
The artemisinin combination therapy market size was valued at USD 363.8 million in 2017. It is projected to expand at a CAGR of 8.5% during the forecast period.
Looking forward, the Menswear market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/menswear-market
Industry Report “Needle-Free Drug Delivery Devices Market Research Report – Forecast to 2023” provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement
See Full Report @ http://goo.gl/uB7udD. Cancer Immunotherapy Drugs will have a market value of about $80 billion in 2020. This report provides a comprehensive overview of the size of cancer immunotherapy market, the segmentation of the market, key players and the vast potential of therapies that are in clinical trials. Oncologic therapeutics cannot cure cancer and yet in 2014, the overall market for cancer therapeutics stood at about $84.3 billion.
Global Needle Free Injection Market Research Report information: Product (Fillable) Technology (Jet-Based) Usability (Reusable), Type of Medication (Liquid-Based), Site of Delivery (Intra dermal), Application (Vaccination) End Users (Hospitals) – Forecast Till 2023
This report provides comprehensive information on the current therapeutic developmental pipeline of Pergamum AB s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Enquiry @ http://www.researchbeam.com/pergamum-ab-product-pipeline-review-2015-market/enquire-about-report
Precision Medicine Market size was over USD 39 billion in 2015, and is anticipated to grow at 10.5% CAGR from 2016 to 2023. Get more details @ https://goo.gl/y9VxzK
“Global Liquid Handling System Market Research Report 2017-2022 By Players, Regions, Product Types & Applications” is a professional and incisive analysis on the market dynamics of the Global Liquid Handling System industry and future growth prospects of the key market players across the globe.
Marketing excellence. Over the past five years, those two words have been the subject of hype and the focus of management attention. As the pharmaceutical industry struggles with market maturation and weakening product pipelines, marketing excellence programmes have been developed and implemented with an eye to overcoming those hurdles.
Projected to grow at a CAGR of around 12%, eClinical solutions market is expected to witness significant growth over the forecast period owing to the increasing demand for software solutions for clinical trials by the pharma and biopharma companies.
A new report available with decisiondatabases.com on Estrogen Receptor Beta Market which provides an in-depth analysis during the forecast period. This report focuses on top manufactures with capacity, production, price, revenue and Market share.
Global Artificial Blood Market is estimated to reach $10.73 billion by 2025; growing at a CAGR of 20.3% from 2017 to 2025. Artificial blood, also known as synthetic blood substitute or blood surrogate is a substance used as a replacement to biological blood. It is intended to offer an alternate to blood transfusion, transfer of blood or blood-based products from one to another individual.
The report provides an analysis of the key trends in each sub-segment of the global engineering services outsourcing market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, service, location and application. The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players. For more information, request for a free sample report here: https://www.imarcgroup.com/engineering-services-outsourcing-market/requestsample
The Vitamin D market is estimated to account for USD 1.1 billion in 2019 and is projected to reach USD 1.7 billion by 2025, at a CAGR of 7.0%. The vitamin D market is driven by growth in awareness of vitamin D deficiency, rise in incidences of osteoporosis in women, and increase in cases of malnutrition in children. However, the regulatory standards for vitamin D are creating a restraint in the market. The rising number of government initiatives and awareness campaigns is expected to create new growth opportunities for the growth of the market.
Industry Experts unveiled the new market research report on Influenza. The new global report ‘Global Influenza Market – Vaccines and Therapeutics’ reveals that the market for seasonal influenza vaccines is estimated at 543 million doses valued at US$4.9 billion in 2016 and projected to touch US$714 million doses equated to US$7.9 billion by 2022. In terms of market value, North America is estimated the largest market with US$2.1 billion in 2016 while Europe is projected to be the fastest growing market for Influenza vaccines during the analysis period 2016-2022 with a CAGR of 11.7%. Hyderabad, India based Industry Experts is a multi industry focused business information provider. For more details, please visit http://industry-experts.com/verticals/healthcare-and-pharma/global-influenza-market-vaccines-and-therapeutics
This report provides comprehensive information on the therapeutic development for Cognitive Impairment Associated with Schizophrenia (CIAS), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cognitive Impairment Associated with Schizophrenia (CIAS) and special features on late-stage and discontinued projects. Enquiry @ http://www.researchbeam.com/cognitive-impairment-associated-with-schizophrenia-cias-pipeline-review-h2-2015-market/enquire-about-report
The report Global Transmucosal Drug Delivery Consumption 2016 Market Research Report covers the whole industry outlook with value chain analysis, DRO's, production and sales volumes and figures.
Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of information and analysis on the global Chemotherapy induced Nausea and Vomiting Therapeutics market.
Medical Informatics Perspectives on Leveraging the Electronic Medical Record in Pharma ... Has been nearly invisible to pharma for numerous reasons, largely due to ...
The leading business intelligence provider, has released its latest research, "Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies", which provides in-depth insights into the indication. It gives an estimation of market size for 2013 along with forecasts until 2020 for the Asia-Pacific (APAC) region, which comprises Australia, China, India and Japan. See Full Report @ bit.ly/1tpBi8j
Ever since it was introduced three decades ago, academic detailing—which now increasingly uses pharma’s sales techniques to educate physicians—has posed a difficult issue for the industry. Governed by a different set of rules, academic detailing is changing the way pharma approaches sales.
Complete report @ http://goo.gl/BAcdzE "The Human Microbiome: Biomedical Implications and Birth of a Market" report covers the evolution of microbiome research and its growth in the commercial market. Specific areas of study include microbial ecology, systems biology, diet, diagnostics, contributions in health and disease, and infectious disease.
ReportsandReports Published New Market Report Titled “Pain Management- New Discoveries And Treatment Options In Abuse Deterrent Era”, spread through 135 pages, discussed emerging novel mechanisms and late stage pipeline drugs in the management of pain. Find Report at http://goo.gl/PMg1Fa.
The global personal protective equipment market is projected to cross $ 93 billion by the end of 2025. Personal protective equipment is intended to ensure adequate safety for laborers and limit any wellbeing and security dangers.
The first step to treating any health condition is diagnosis.In our special issue of “10 Leading Diagnostic Solution Providers 2019”, we have featured top diagnostic companies that have not only enabled correct detection of diseases but have aided in early diagnosis and are contributing largely to the better tomorrow of healthcare.
Outsource It to Chinese' (New York Times, page 1 news section). The 'factory': Fuzhou, China. ... headline, Newsweek, 0313.06. Last 3 years: ... CNN ... Nike ' ...
From a strategic perspective, the New York area's most critical assets to Stern ... Sources: 1999 Fortune 1000 data; Cranes 6/5/00; A.T. Kearney analysis ...
With an idea to acknowledge the fast-growing companies, contributing extraordinarily to the revolution of disruption in healthcare, we bring to you the special edition of “The 20 Most Disruptive Healthcare Solution Providers 2018”.